COO vs DXCM: fair value comparison
The Cooper Companies, Inc. and DexCom, Inc. · Updated 2026-09-07
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, COO currently sits closer to the top of our discount ranking.
| COO | DXCM | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $69.59 | $87.90 |
| 12-month range | $60.19–$83.92 | $58.22–$90.14 |
| Sector rank | #16 of 113 Healthcare | #20 of 113 Healthcare |
| Quality grade | A | A |
| Momentum grade | A | A |
| Leverage | Low | Moderate |
| Margin trend | Stable | Contracting |
| Revenue growth | Modest | Strong |
| RSI zone | Neutral | Neutral |
| 50/200-day trend | Downtrend | Uptrend |
| DCF cross-check | Overvalued | — |
| 52-week position | The lower-middle quarter | The top quarter |
Full single-stock breakdowns: COO fair value analysis · DXCM fair value analysis